Upstream Bio, Inc. (UPB) — Financial ratios
Profitability, liquidity, leverage, and valuation ratios for Upstream Bio, Inc., with annual and quarterly history.
| Metric | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Valuation | ||||
| P/E Ratio | -10.19x | -13.44x | -38.91x | -33.48x |
| P/B Ratio | 4.30x | 1.80x | -6.49x | -7.53x |
| P/S Ratio | 512.30x | 356.14x | 335.76x | 659.33x |
| Profitability | ||||
| Gross Margin | 100.0% | 100.0% | 100.0% | 100.0% |
| Operating Margin | -5618.8% | -3281.2% | -1685.5% | -1972.7% |
| Net Margin | -5026.0% | -2650.0% | -862.9% | -1969.3% |
| EBITDA Margin | -5612.2% | -3277.4% | -1682.9% | -1972.1% |
| Liquidity | ||||
| Current Ratio | 26.15x | 44.63x | 17.96x | 3.77x |
| Quick Ratio | 26.15x | 44.63x | 17.96x | 3.77x |
| Leverage | ||||
| Debt/Equity | 0.00x | 0.00x | -0.00x | -0.00x |
YoY = year-over-year change. Source: FMP..